KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Depreciation & Amortization (CF) (2016 - 2025)

Biogen (BIIB) has 17 years of Depreciation & Amortization (CF) data on record, last reported at $200.2 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 8.8% year-over-year to $200.2 million; the TTM value through Dec 2025 reached $779.9 million, up 15.85%, while the annual FY2025 figure was $779.9 million, 15.85% up from the prior year.
  • Depreciation & Amortization (CF) reached $200.2 million in Q4 2025 per BIIB's latest filing, down from $202.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $202.2 million in Q3 2025 and bottomed at $102.6 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $147.7 million, with a median of $137.4 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): fell 21.52% in 2023, then soared 46.24% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $134.7 million in 2021, then fell by 11.06% to $119.8 million in 2022, then rose by 16.94% to $140.1 million in 2023, then soared by 31.33% to $184.0 million in 2024, then increased by 8.8% to $200.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $200.2 million in Q4 2025, $202.2 million in Q3 2025, and $194.3 million in Q2 2025.